Botox Gets The Fda Ok For Migraine Headaches

By ·
Botox Gets The Fda Ok For Migraine Headaches featured image

After years of anecdotal evidence from patients, off-label usage, and landmark studies, the FDA has approved Botox for the treatment of chronic migraine headaches.

Allergan has been given the green light to begin marketing their wrinkle-relaxing injectable as an option for people who suffer from debilitating migraines at least 15 days each month. It is not intended for those who suffer from few-and-far-between migraines.

The decision came after two major studies involving over 1,000 patients, some of whom received Botox injections while others received a placebo injection. Those who received the Botox injections reported two fewer “headache days” per month than the other patients.

This isn’t the first non-cosmetic FDA approval Botox has received in 2010. Earlier this year, it was cleared for the treatment of elbow, wrist and finger spasms.

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.